Edwards Lifesciences (EW) Minority Interest (2023 - 2026)

Edwards Lifesciences has reported Minority Interest for 4 years, with the latest figure at $106.9 million in Q2 2026.

• On a quarterly basis, Minority Interest rose 74.67% year-over-year to $106.9 million in Q2 2026; TTM through Jun 2026 was $106.9 million, a 74.67% increase from a year earlier, with the FY2024 full-year figure at $64.5 million, down 7.06% from the prior year.
• Minority Interest was $106.9 million for Q2 2026 at Edwards Lifesciences, up from $61.2 million in the prior quarter.
• The five-year high for Minority Interest was $106.9 million in Q2 2026, with the low at $61.2 million in Q2 2025.
• Average Minority Interest over 4 years is $71.9 million, with a median of $68.5 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Minority Interest decreased 18.45% in 2024, then jumped 74.67% in 2026.
• Over 4 years, Minority Interest stood at $69.4 million in 2023, then dropped by 7.06% to $64.5 million in 2024, then declined by 5.12% to $61.2 million in 2025, then surged by 74.67% to $106.9 million in 2026.
• The last three Minority Interest figures came in at $106.9 million (Q2 2026), $61.2 million (Q2 2025), and $62.9 million (Q1 2025), per Business Quant data.